Diana A Coffa, MD
Family Practice · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 20 years
- University of California, San Francisco School of Medicine, 2006
Offices
1 location · University of California Sfgh Medical Group · 566 clinicians in this group
Looking this up.
Hospitals listed: Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Coffa’s office at (628) 206-4774 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A104173 · Current
Licensed to practise in California · since 2008 · expires 2027-10-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Preventive Medicine - Addiction Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.37 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.538 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 667 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.76 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.34 (147.34 to 243.34) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.5 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 214 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 261 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,351 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.5) · 4,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.39 (0.19 to 0.59) · 4,644 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.11 to 6.56) · 795 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.33 to 4.38) · 861 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (0.25 to 17.64) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6 (2.01 to 9.98) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 167 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0.08 to 1.49) · 4,129 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.709 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.769 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 227 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 75.1 · 239 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (8.3 to 15.1) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 17.9) · 966 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.7) · 88 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,644 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$13,252
Medicare paid this office $13,252 for 74 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $6,208 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,151 | $154 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,970 | $116 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,355 | $104 |
Who their Medicare patients are
74 Original Medicare patients in 2024. Average age 69 · Under 65 26% · Women 46% · Health risk score 3.78. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 66% · COPD 53% · Chronic kidney disease 49% · Coronary heart disease 47% · Heart failure 43% · Depression 41% · Dementia 34% · Atrial fibrillation 27% · Stroke 24% · Cancer 23%.
The office billed $71,123, Medicare allowed $16,734 and paid $13,252; for 160 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 74 | 160 | 69 | 3.78 | $71,123 | $13,252 |
| 2023 | 77 | 201 | 72 | 3.02 | $85,300 | $16,232 |
| 2022 | 67 | 173 | 69 | 2.13 | $60,974 | $11,577 |
| 2021 | 55 | 164 | 71 | 3.12 | $60,534 | $11,747 |
| 2020 | 62 | 126 | 69 | 2.53 | $55,514 | $10,403 |
| 2019 | 81 | 193 | 70 | 3.08 | $80,145 | $15,251 |
| 2018 | 68 | 185 | 70 | 2.95 | $80,886 | $15,290 |
| 2017 | 74 | 204 | 69 | 2.61 | $86,488 | $15,813 |
| 2016 | 75 | 157 | 68 | 2.86 | $71,441 | $12,856 |
| 2015 | 31 | 80 | 67 | 3.60 | $33,688 | $6,759 |
| 2014 | 44 | 114 | 68 | 2.74 | $45,925 | $8,539 |
| 2013 | 38 | 101 | 68 | 2.21 | $39,717 | $7,078 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $7,183 | $70 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,422 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,360 | $157 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,530 | $118 |
2022: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,823 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,911 | $174 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $1,785 | $34 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,692 | $94 |
2021: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $5,266 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,327 | $179 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,546 | $97 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $1,370 | $34 |
2020: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,795 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,094 | $182 |
| Hospital discharge day management, more than 30 minutes | 20 | $1,828 | $91 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,147 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,979 | $175 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,125 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,369 | $105 |
2018: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $6,709 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,149 | $173 |
| Hospital discharge day management, more than 30 minutes | 34 | $3,187 | $94 |
2017: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $7,020 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,637 | $165 |
| Hospital discharge day management, more than 30 minutes | 29 | $3,043 | $92 |
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $5,914 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,470 | $158 |
| Hospital discharge day management, more than 30 minutes | 27 | $2,543 | $94 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,649 | $65 |
2014: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $4,979 | $59 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,748 | $97 |
2013: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,644 | $60 |
| Hospital discharge day management, 30 minutes or less | 23 | $1,551 | $65 |
Medicaid work
$46,581 in 2024
Medicaid paid $46,581 for 406 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 116 | $39,282 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 135 | $7,299 |
| Short return visit (20+ min) | 86 | $0 |
| Service | 69 | $0 |
| 2024 | 406 | 4 | 26 | $46,581 |
| 2023 | 477 | 4 | 28 | $44,322 |
| 2022 | 161 | 4 | 19 | $17,379 |
| 2021 | 833 | 5 | 54 | $92,544 |
| 2020 | 350 | 4 | 27 | $35,216 |
| 2019 | 346 | 5 | 28 | $43,592 |
| 2018 | 499 | 4 | 25 | $72,653 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 128 | $41,584 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 128 | $2,664 |
| Short return visit (20+ min) | 141 | $75 |
| Service | 80 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 48 | $15,184 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 59 | $2,194 |
| Short return visit (20+ min) | 38 | $0 |
| Service | 16 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 278 | $87,803 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 157 | $4,510 |
| Short return visit (20+ min) | 259 | $197 |
| Return visit (30+ min) | 31 | $34 |
| Service | 108 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 112 | $33,366 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 73 | $1,720 |
| Short return visit (20+ min) | 137 | $129 |
| Service | 28 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 135 | $41,264 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 121 | $1,734 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 17 | $525 |
| Short return visit (20+ min) | 54 | $69 |
| Service | 19 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 224 | $68,302 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 203 | $3,563 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 18 | $661 |
| Short return visit (20+ min) | 54 | $127 |
Drugs they prescribed that Part D paid
$67,957
Pharmacies billed $67,957 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (44 of 595) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 25% of their opioid prescriptions.
544 generic and fewer than 11 brand-name prescriptions · $67,957 in drug cost · 18 antibiotic prescriptions · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 11 | $8,253 | $750 |
| Fentanyl | 11 | $967 | $88 |
| Oxycodone | 32 | $634 | $20 |
| Cyclobenzaprine | 12 | $588 | $49 |
| Mirtazapine | 18 | $369 | $21 |
See all 17 drugs
| Jardiance | 11 | $8,253 | $750 |
| Fentanyl | 11 | $967 | $88 |
| Oxycodone | 32 | $634 | $20 |
| Cyclobenzaprine | 12 | $588 | $49 |
| Mirtazapine | 18 | $369 | $21 |
| Metoprolol | 16 | $227 | $14 |
| Amlodipine Besylate | 29 | $172 | $6 |
| Hydrocortisone | 15 | $136 | $9 |
| Pantoprazole | 22 | $102 | $5 |
| Atorvastatin | 30 | $96 | $3 |
| Famotidine | 11 | $78 | $7 |
| Sertraline | 23 | $74 | $3 |
| Quetiapine | 14 | $73 | $5 |
| Benazepril | 15 | $47 | $3 |
| Metformin | 12 | $42 | $3 |
| Lorazepam | 11 | $20 | $2 |
| Metformin Hcl Er | 13 | $13 | $1 |
Year by year
| 2024 | 595 | 67 | 7% (44) | None | $67,957 |
| 2023 | 631 | 83 | 9% (58) | None | $91,797 |
| 2022 | 574 | 73 | 10% (58) | None | $71,597 |
| 2021 | 519 | 68 | 9% (45) | None | $59,852 |
| 2020 | 507 | 56 | 9% (44) | None | $45,762 |
| 2019 | 521 | 54 | 8% (39) | None | $44,934 |
| 2018 | 448 | 35 | 8% (36) | None | $29,098 |
| 2017 | 529 | 34 | 8% (43) | None | $34,432 |
| 2016 | 599 | 44 | 9% (54) | None | $54,990 |
| 2015 | 538 | 41 | 11% (59) | None | $45,924 |
| 2014 | 298 | 48 | 16% (47) | 16% | $21,867 |
| 2013 | 721 | 112 | 10% (75) | None | $44,934 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Jardiance | 13 | $11,669 | $898 |
| Fentanyl | 13 | $2,642 | $203 |
| Oxycodone | 44 | $1,628 | $37 |
| Atorvastatin | 33 | $1,039 | $31 |
| Cyclobenzaprine | 13 | $929 | $71 |
| Metoprolol | 19 | $803 | $42 |
| Albuterol Sulfate Hfa | 11 | $652 | $59 |
| Pantoprazole | 25 | $561 | $22 |
| Amlodipine Besylate | 35 | $497 | $14 |
| Gabapentin | 15 | $497 | $33 |
| Pravastatin | 12 | $401 | $33 |
| Benazepril | 16 | $358 | $22 |
| Diclofenac | 13 | $345 | $27 |
| Ibuprofen | 16 | $323 | $20 |
| Sertraline | 17 | $235 | $14 |
| Metformin | 11 | $168 | $15 |
| Trazodone | 12 | $152 | $13 |
| Lorazepam | 15 | $46 | $3 |
2022: 15 drugs
| Creon | 14 | $15,244 | $1,089 |
| Oxycodone | 49 | $1,883 | $38 |
| Albuterol Sulfate Hfa | 13 | $738 | $57 |
| Sertraline | 18 | $430 | $24 |
| Pravastatin | 14 | $382 | $27 |
| Amlodipine Besylate | 24 | $255 | $11 |
| Atorvastatin | 11 | $255 | $23 |
| Benazepril | 23 | $247 | $11 |
| Finasteride | 17 | $234 | $14 |
| Diclofenac | 11 | $203 | $18 |
| Metformin | 15 | $202 | $13 |
| Ibuprofen | 20 | $144 | $7 |
| Tamsulosin | 11 | $134 | $12 |
| Pantoprazole | 11 | $114 | $10 |
| Lorazepam | 17 | $40 | $2 |
2021: 14 drugs
| Creon | 13 | $13,080 | $1,006 |
| Symbicort | 15 | $5,801 | $387 |
| Oxycodone | 36 | $1,554 | $43 |
| Omeprazole | 14 | $416 | $30 |
| Amlodipine Besylate-Benazepril | 12 | $321 | $27 |
| Metoprolol | 11 | $275 | $25 |
| Pantoprazole | 15 | $264 | $18 |
| Lorazepam | 27 | $253 | $9 |
| Gabapentin | 13 | $248 | $19 |
| Amlodipine Besylate | 18 | $241 | $13 |
| Ibuprofen | 21 | $239 | $11 |
| Sertraline | 12 | $159 | $13 |
| Benazepril | 12 | $141 | $12 |
| Metformin | 13 | $63 | $5 |
2020: 17 drugs
| Ondansetron Odt | 14 | $1,942 | $139 |
| Oxycodone | 27 | $1,227 | $45 |
| Mirtazapine | 11 | $857 | $78 |
| Diclofenac | 15 | $709 | $47 |
| Gabapentin | 14 | $383 | $27 |
| Pravastatin | 16 | $293 | $18 |
| Terazosin | 11 | $283 | $26 |
| Omeprazole | 11 | $220 | $20 |
| Benazepril | 17 | $206 | $12 |
| Atorvastatin | 14 | $188 | $13 |
| Amlodipine Besylate-Benazepril | 12 | $159 | $13 |
| Lidocaine | 13 | $157 | $12 |
| Lorazepam | 15 | $141 | $9 |
| Pantoprazole | 13 | $138 | $11 |
| Cyclobenzaprine | 11 | $133 | $12 |
| Amlodipine Besylate | 14 | $110 | $8 |
| Metformin | 11 | $87 | $8 |
2019: 15 drugs
| Spiriva Respimat | 16 | $7,223 | $451 |
| Oxycodone | 26 | $1,071 | $41 |
| Amlodipine Besylate-Benazepril | 18 | $1,025 | $57 |
| Gabapentin | 21 | $903 | $43 |
| Diclofenac | 19 | $862 | $45 |
| Terazosin | 16 | $489 | $31 |
| Omeprazole | 11 | $411 | $37 |
| Lidocaine | 16 | $223 | $14 |
| Atorvastatin | 13 | $203 | $16 |
| Ibuprofen | 11 | $182 | $17 |
| Hydrochlorothiazide | 18 | $155 | $9 |
| Sertraline | 13 | $152 | $12 |
| Metformin | 12 | $129 | $11 |
| Benazepril | 16 | $129 | $8 |
| Amlodipine Besylate | 15 | $109 | $7 |
2018: 13 drugs
| Spiriva Respimat | 12 | $4,762 | $397 |
| Oxycodone | 24 | $930 | $39 |
| Ventolin Hfa | 16 | $886 | $55 |
| Pravastatin | 19 | $836 | $44 |
| Lidocaine | 19 | $801 | $42 |
| Amlodipine Besylate-Benazepril | 11 | $677 | $62 |
| Gabapentin | 15 | $341 | $23 |
| Sertraline | 16 | $193 | $12 |
| Benazepril | 21 | $185 | $9 |
| Fluticasone Propionate | 14 | $153 | $11 |
| Ibuprofen | 12 | $134 | $11 |
| Hydrochlorothiazide | 11 | $123 | $11 |
| Amlodipine Besylate | 18 | $107 | $6 |
2017: 17 drugs
| Spiriva Respimat | 12 | $4,422 | $368 |
| Metoprolol | 20 | $1,474 | $74 |
| Oxycodone | 26 | $991 | $38 |
| Pravastatin | 20 | $771 | $39 |
| Gabapentin | 22 | $631 | $29 |
| Hydrocodone-Acetaminophen | 11 | $451 | $41 |
| Benazepril | 35 | $321 | $9 |
| Omeprazole | 12 | $198 | $16 |
| Terazosin | 12 | $179 | $15 |
| Sertraline | 16 | $176 | $11 |
| Topiramate | 13 | $161 | $12 |
| Amlodipine Besylate | 26 | $151 | $6 |
| Hydrochlorothiazide | 18 | $107 | $6 |
| Metformin | 13 | $102 | $8 |
| Mirtazapine | 11 | $91 | $8 |
| Triamcinolone Acetonide | 11 | $78 | $7 |
| Lorazepam | 11 | $17 | $2 |
2016: 18 drugs
| Spiriva Respimat | 13 | $4,372 | $336 |
| Lidocaine | 14 | $2,800 | $200 |
| Metoprolol | 29 | $1,850 | $64 |
| Pravastatin | 23 | $1,522 | $66 |
| Oxycodone | 30 | $1,195 | $40 |
| Gabapentin | 34 | $956 | $28 |
| Hydrocodone-Acetaminophen | 11 | $632 | $57 |
| Morphine Sulfate Er | 13 | $431 | $33 |
| Benazepril | 37 | $416 | $11 |
| Terazosin | 13 | $388 | $30 |
| Sertraline | 26 | $367 | $14 |
| Mirtazapine | 18 | $246 | $14 |
| Clotrimazole | 12 | $241 | $20 |
| Ibuprofen | 12 | $239 | $20 |
| Amlodipine Besylate | 26 | $202 | $8 |
| Metformin | 22 | $200 | $9 |
| Hydrochlorothiazide | 18 | $71 | $4 |
| Lorazepam | 11 | $18 | $2 |
2015: 14 drugs
| Nexium | 11 | $10,427 | $948 |
| Oxycodone | 28 | $1,134 | $40 |
| Metoprolol | 23 | $979 | $43 |
| Pravastatin | 16 | $929 | $58 |
| Hydrocodone-Acetaminophen | 17 | $791 | $47 |
| Benazepril | 37 | $274 | $7 |
| Sertraline | 24 | $245 | $10 |
| Gabapentin | 13 | $181 | $14 |
| Alendronate | 13 | $156 | $12 |
| Mirtazapine | 15 | $142 | $9 |
| Amlodipine Besylate | 31 | $142 | $5 |
| Metformin | 19 | $103 | $5 |
| Hydrocortisone | 11 | $96 | $9 |
| Hydrochlorothiazide | 18 | $78 | $4 |
2014: 6 drugs
| Oxycodone | 20 | $1,410 | $71 |
| Morphine Sulfate Er | 13 | $1,017 | $78 |
| Hydrocodone-Acetaminophen | 12 | $404 | $34 |
| Benazepril | 20 | $167 | $8 |
| Hydrochlorothiazide | 15 | $77 | $5 |
| Amlodipine Besylate | 12 | $74 | $6 |
2013: 21 drugs
| Symbicort | 11 | $2,658 | $242 |
| Diovan | 12 | $1,499 | $125 |
| Oxycodone | 27 | $1,088 | $40 |
| Morphine Sulfate Er | 17 | $1,058 | $62 |
| Metoprolol | 18 | $1,006 | $56 |
| Metformin | 56 | $729 | $13 |
| Hydrocodone-Acetaminophen | 21 | $666 | $32 |
| Pravastatin | 20 | $662 | $33 |
| Atorvastatin | 16 | $521 | $33 |
| Amlodipine Besylate | 37 | $420 | $11 |
| Paroxetine | 15 | $315 | $21 |
| Losartan | 14 | $311 | $22 |
| Terazosin | 24 | $287 | $12 |
| Simvastatin | 35 | $248 | $7 |
| Benazepril | 26 | $227 | $9 |
| Lisinopril | 13 | $212 | $16 |
| Levothyroxine | 12 | $192 | $16 |
| Sertraline | 17 | $180 | $11 |
| Glipizide | 13 | $154 | $12 |
| Hydrochlorothiazide | 22 | $97 | $4 |
| Mirtazapine | 12 | $89 | $7 |
Professional record
- NPI
- 1669631396
- Licence
- CA A104173California A104173: Current · expires 2027-10-31
- Trained
- University of California, San Francisco School of Medicine, 2006 · 20 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 995 Potrero Ave, Sfgh, Building 80, Ward 83, San Francisco, CA, 94110
- NPI first listed
- 2008-06-06
- NPI last updated
- 2008-06-06
This is when the NPI record was last certified, not a medical board exam.